[Form 4] ARAMARK Insider Trading Activity

Rhea-AI Filing Summary

Richard W. Dreiling, a director of Aramark (ARMK), received dividend-equivalent rights that converted to 18.645 shares on 08/20/2025 at no cost to him. After the transaction he beneficially owned 6,267.292 shares. The filing states these dividend-equivalent rights accrued on deferred stock units and vest on the same schedule as the underlying awards. The Form 4 was signed by an attorney-in-fact on 08/21/2025.

Positive

• Dividend-equivalent credit increased the director's holdings without cash outlay, reflecting standard compensation mechanics
• Clear disclosure of nature of award and vesting schedule provides transparency for investors

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine insider crediting of dividend-equivalents; minor share increase and no cash exchanged.

This Form 4 reports a common, non-cash issuance of 18.645 shares to a director via dividend-equivalent rights tied to deferred stock units, increasing his beneficial ownership to 6,267.292 shares. The transaction appears administrative and not indicative of change in investment intent or company fundamentals. For investors, this is a routine disclosure that marginally adjusts insider share counts but is unlikely to materially affect valuation.

Corporate Governance Expert

TL;DR: Standard governance disclosure of dividend-equivalent vesting; no governance red flags visible.

The filing clearly identifies the reporting person as a director and specifies the nature of the issuance as dividend-equivalent rights that vest with the underlying awards. The transaction code and explanation align with typical deferred compensation mechanics. Signature by an attorney-in-fact is noted and the form appears complete. There are no indications of unusual related-party transactions or departures from standard compensation practices.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DREILING RICHARD W

(Last) (First) (Middle)

C/O ARAMARK

2400 MARKET STREET

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/20/2025		A		18.645(1)	A	$0	6,267.292	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 for ARMK filed by Richard W. Dreiling report?

The Form 4 reports that on 08/20/2025 Mr. Dreiling received 18.645 shares as dividend-equivalent rights resulting in total beneficial ownership of 6,267.292 shares.

Was any cash paid for the shares reported in the ARMK Form 4?

No. The filing shows a price of $0, indicating the shares were credited as dividend-equivalent rights tied to deferred stock units.

What is the nature of the award credited to the ARMK director?

The filing states these were dividend equivalent rights accrued on deferred stock units and they vest on the same schedules as the underlying awards.

Who signed the Form 4 for Richard W. Dreiling and when?

The Form 4 was signed by Ryan S. Spengler, as Attorney-in-fact on 08/21/2025.

Does this Form 4 indicate any change in Dreiling's role at ARMK?

No. The filing identifies Dreiling as a Director and does not state any change in his relationship to the issuer.